Table 1 Twelve (C-12) protein biochip test results of healthy, benign pancreatic and pancreatic cancer subjects
From: Multiple tumor marker protein chip detection system in diagnosis of pancreatic cancer
Healthy | Benign pancreatic | Pancreatic cancer | P-value | |
|---|---|---|---|---|
(n =240) | (n =230) | (n =235) | (SNK method) | |
CA19-9 (U/ml) | 4.5 ± 2. 8 | 16.4 ± 19.2 | 203.8 ± 296.5 | 0. 0008 |
CA125 (U/ml) | 2.9 ± 2. 6 | 18.9 ± 28.7 | 174.6 ± 266.2 | 0. 0016 |
FER (ng/ml) | 118.9 ± 62.6 | 320.9 ± 285 | 373.8 ± 385.5 | 0. 5579 |
CA242 (U/ml) | 2.3 ± 0.8 | 9.3 ± 14.7 | 130.5 ± 150.5 | 0. 0035 |
CEA (ng/ml) | 1.1 ± 0.5 | 1.87 ± 2.3 | 13.5 ± 27.1 | 0. 0392 |
CA15-3 (U/ml) | 5.1 ± 4.2 | 13.4 ± 6.8 | 79.4 ± 82.3 | 0. 0584 |
β-HCG (mIU/ml) | 0.1 ± 0.1 | 0.5 ± 0.4 | 8.96 ± 12.8 | 0. 0694 |
AFP (ng/ml) | 3.3 ± 2.4 | 1.6 ± 1.8 | 14.5 ± 36.8 | 0. 0568 |
NSE (ng/ml) | 1.3 ± 0.8 | 2.1 ± 2.3 | 7.9 ± 12.8 | 0. 0179 |
PSA (ng/ml) | 0.3 ± 0.2 | 0.6 ± 0.5 | 1.5 ± 2.38 | 0. 0575 |
f-PSA (ng/ml) | 0.1 ± 0.1 | 0.2 ± 0.2 | 0.6 ± 0.6 | 0. 1046 |
HGH (ng/ml) | 0.1 ± 0.2 | 0.8 ± 0.7 | 4.5 ± 4.8 | 0. 0564 |